Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.60777
+0.0078 (1.30%)
May 6, 2026, 4:23 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 20.73 million as of May 6, 2026. Its market cap has increased by 300.40% in one year.
Market Cap
20.73M
Enterprise Value
19.54M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.61
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 20.73M, a decrease of -78.75%. That is a compound annual growth rate of -29.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 20.73M | -28.50% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 50.50M |
| Hemogenyx Pharmaceuticals | 43.69M |
| Poolbeg Pharma | 31.73M |
| Sareum Holdings | 27.96M |
| SkinBioTherapeutics | 25.27M |
| ImmuPharma | 24.96M |
| Arecor Therapeutics | 24.92M |
| Fusion Antibodies | 15.63M |